|
|
 |
CALCIUM SULFATE DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CARRAGEENAN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CALQUENCE Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CALCIUM ACETATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CABTREO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CAPRELSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
BUTANE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CALCIUM CHLORIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CARBOXYMETHYLCELLULOSE SODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|